| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 51,762 | 35,567 | 32,627 | 67,525 | | Cost of Revenue | 36,181 | 27,636 | 26,239 | 49,128 | | | Gross Profit | 15,581 | 7,931 | 6,388 | 18,397 | | | Operating Expenses | | Research Development | 10,195 | 10,742 | 11,098 | 13,424 | | Selling General and Administrative | 10,788 | 10,166 | 9,395 | 9,513 | | Non Recurring | 235 | 739 | 66,656 | 1,898 | | Others | 123 | 120 | 222 | 257 | | | | Total Operating Expenses | 21,341 | 21,767 | 87,371 | 25,092 | | | | Operating Income or Loss | (5,760) | (13,836) | (80,983) | (6,695) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 506 | 627 | 282 | 553 | | Earnings Before Interest And Taxes | (5,254) | (13,209) | (80,701) | (6,142) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (5,254) | (13,209) | (80,701) | (6,142) | | Income Tax Expense | 3,177 | 2,825 | (938) | 12,835 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,431) | (16,034) | (79,763) | (18,977) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,431) | (16,034) | (79,763) | (18,977) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,431) | ($16,034) | ($79,763) | ($18,977) |
|
0.51% Nasdaq 
0.14 (0.94%) 
Income Statement
